TrialBlood neoplasia2024

Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS.

Jad Othman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.